+
Site Tour

Webinar 2022: Management of aortic and mitral valve disease

Torsten Doenst et al. Focus on the management of aortic and mitral valve disease with future treatment in mind. Including quality of life, preserving the long-treatment path, and the role of porcine tissue valves during a recorded webinar.

Related Videos

Navitor™: Voice of the Experts Nicolas Van Mieghem

M-TEER: patient selection and current evidence

T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks

Review the Trends | Tricuspid focus

EuroPCR 2022: Tendyne™

EACVI Summit 2023: Congress symposium

AV VALVES 2023: HoloLens Technology

TAVI Summit - What is coming next

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

ESC 2021: HF & VHD Guidelines

EuroPCR 2022: TAVI 1yr outcomes

Epic Mitral – 10-Year Clinical Outcomes

PCR LV 2021: Navitor™ Looking ahead

CONNEXT


LIVE
RELATED EVENTS

AV VALVES 2023: Trending Topics – QoL

Now you've got Navitor.
Future ready.

TAVI Summit 2023: Morphology

EuroPCR 2023: Defining the future

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline